Gainers
- Kiromic BioPharma, Inc. KRBP shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public offering to which the registration statement relates.
- MSP Recovery, Inc. MSPR shares rose 37.2% to $2.95 in pre-market trading after the company issued a business update. MSP Recovery recently posted Q2 loss of $0.09 per share.
- Signify Health, Inc. SGFY rose 36.8% to $29.00 in pre-market trading after the Wall Street Journal reported that Amazon is among the potential bidders for the healthcare company, along with the previously reported CVS.
- Wag! Group Co. PET rose 34.8% to $7.00 in pre-market trading after jumping around 9% on Friday. DA Davidson maintained buy on Wag Group and lowered price target to $11 .
- AnPac Bio-Medical Science Co., Ltd. ANPC rose 28% to $0.2745 in pre-market trading after declining 8% on Friday. Anpac Bio-Medical Science recently named Yuyang Cui as Co-Chairman and co-CEO.
- Reborn Coffee, Inc. REBN rose 21.9% to $4.45 in pre-market trading after declining 8% on Friday. Reborn Coffee recently announced closing of upsized $7.2 million initial public offering.
- Graphex Group Limited GRFX shares rose 20.4% to $3.01 in pre-market trading after gaining 21% on Friday. Graphex Group reported closing of upsized $11.7 million public offering and NYSE American listing.
- Greenbrook TMS Inc. GBNH rose 17.5% to $3.61 in pre-market trading after jumping around 30% on Friday.
- 180 Life Sciences Corp. ATNF rose 14% to $1.08 in pre-market trading. 180 Life Sciences, last month, announced a $6.5 million registered direct offering.
- Better Therapeutics, Inc. BTTX shares rose 13.1% to $1.81 in pre-market trading. Better Therapeutics recently reported Q2 R&D expenses of $4.2 million.
- GigaCloud Technology Inc. GCT rose 11% to $53.29 in pre-market trading after jumping 206% on Friday.
- Apexigen, Inc. APGN rose 10.8% to $6.17 in pre-market trading after declining around 5% on Friday.
- Austin Gold Corp.AUST rose 10.7% to $1.86 in pre-market trading.
- Kala Pharmaceuticals, Inc. KALA rose 9.4% to $0.3391 in pre-market trading. Kala Pharmaceuticals reported inducement grant under NASDAQ listing rule 5635(c)(4).
- Adagio Therapeutics, Inc ADGI rose 9.1% to $4.58 in pre-market trading after declining around 7% on Friday. Adagio Therapeutics recently posted a Q2 loss of $0.47 per share.
- Mind Medicine (MindMed) Inc. MNMD rose 7.3% to $0.9090 in pre-market trading after dropping 17% on Friday.
- Veru Inc. VERU rose 7% to $18.70 in pre-market trading. Veru named Jason Davies as Executive Vice President – General Manager of Europe, the Middle East and Africa (EMEA), Latin America (LATAM), and Asia Pacific (APAC)
for Veru’s Infectious Disease Franchise for Veru International.
Don’t forget to check out our premarket coverage here .
Losers
- AMC Entertainment Holdings, Inc. AMC shares fell 33% to $12.08 in pre-market trading after Cineworld confirmed possible bankruptcy filing.
- Assure Holdings Corp. IONM fell 30% to $0.98 in pre-market trading after the company reported a proposed underwritten public offering of common stock.
- Advanced Emissions Solutions, Inc. ADES shares fell 20.4% to $5.10 in pre-market trading after the company reported a merger with Arq Limited.
- Golden Sun Education Group Limited GSUN fell 16.5% to $42.30 in pre-market trading after dropping 23% on Friday.
- Aeglea BioTherapeutics, Inc. AGLE fell 13.4% to $0.7879 in pre-market trading. Aeglea BioTherapeutics shares jumped 80% on Friday after the company announced a marketing authorization application for pegzilarginase for the treatment of Arginase 1 deficiency has been submitted to and successfully validated by the European Medicines Agency.
- Heart Test Laboratories, Inc. HSCS fell 12% to $1.76 in pre-market trading after dropping over 10% on Friday. Heart Test Laboratories was recently granted European Patent titled 'Electrode And Cable Connections In Electrocardiography Systems.'
- OncoCyte Corporation OCX fell 11.5% to $0.80 in pre-market trading. OncoCyte recently posted a Q2 loss of $0.07 per share.
- Hydrofarm Holdings Group, Inc. HYFM fell 11.3% to $3.77 in pre-market trading. The company's co-CEO, last week, disclosed a purchase of 25,000 shares at an average price of $3.73 per share.
- Nova LifeStyle, Inc. NVFY fell 10.6% to $0.80 in pre-market trading. Nova Lifestyle recently posted Q2 sales of $3.80 million.
- Marker Therapeutics, Inc. MRKR fell 10.2% to $0.3104 in pre-market trading. Marker Therapeutics recently posted a Q2 loss of $0.11 per share.
- Otonomy, Inc. OTIC shares fell 9.5% to $0.3801 in pre-market trading on volatility.
- Plains GP Holdings, L.P. PAGP fell 8.3% to $10.95 in pre-market trading. The company recently released Q2 results.
- StoneCo Ltd. STNE fell 6.4% to $8.49 in pre-market trading. StoneCo shares dropped 22% on Friday after the company reported Q2 earnings results.
- GameStop Corp. GME fell 5.6% to $34.45 in pre-market trading after dropping around 4% on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in